Using Behavioral Economics and Technology to Improve Outcomes in Cardio-Oncology
Patients with cancer are often at elevated risk for cardiovascular disease due to overlapping risk factors and cardiotoxic anticancer treatments. Their cancer diagnoses may be the predominant focus of clinical care, with less of an emphasis on concurrent cardiovascular risk management. Widely adopte...
Main Authors: | Kimberly J. Waddell, PhD, Payal D. Shah, MD, Srinath Adusumalli, MD, MSc, Mitesh S. Patel, MD, MBA, MS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | JACC. CardioOncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087320300144 |
Similar Items
-
The Establishment of the Nordic Cardio-Oncology Society
by: Agneta Månsson Broberg, MD, PhD, et al.
Published: (2020-06-01) -
Cardio-Oncology in China
by: Yuhui Zhang, MD, et al.
Published: (2020-03-01) -
Cardio-Oncology in Israel
by: Zaza Iakobishvili, MD, PhD, et al.
Published: (2019-12-01) -
Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity
by: Richard K. Cheng, MD, MSc, et al.
Published: (2019-12-01) -
21st Century Cardio-Oncology
by: Calvin Chen Sheng, MD, et al.
Published: (2016-08-01)